Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Crane

Showing results (201-210 of 301) with videos related to

Pageof 31
Sort By:
Practical Radiation Oncology|January 17, 2017
Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancerH D Heerkens, W A Hall, X A Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response AnalysisRanda Tao, Sunil Krishnan, Priya R Bhosale, et al.
Plos One|December 24, 2014
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implicationsChaitanya R Churi, Rachna Shroff, Ying Wang, et al.
Frontiers in Oncology|October 3, 2022
Radiation therapy for <i>de novo</i> anorectal cancer in patients with a history of prostate radiation therapyLara Hilal, Abraham J Wu, Marsha Reyngold, et al.
International Journal of Radiation Oncology, Biology, Physics|March 14, 2023
Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic CancerMarsha Reyngold, Sana D Karam, Carla Hajj, et al.
Annals of Surgical Oncology|January 20, 2012
Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapyChing-Wei D Tzeng, Jason B Fleming, Jeffrey E Lee, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 3, 2013
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancerChing-Wei D Tzeng, Aparna Balachandran, Mediha Ahmad, et al.
Advances in Radiation Oncology|June 17, 2025
Prospective Evaluation of a Novel Unidirectional Permanent Device for Intraoperative BrachytherapyAbraham J Wu, Irini Youssef, Gil'ad N Cohen, et al.
JAMA Oncology|March 11, 2021
Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic CancerMarsha Reyngold, Eileen M O'Reilly, Anna M Varghese, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancerChristopher H Crane, Lee M Ellis, James L Abbruzzese, et al.
Pageof 31

Showing results (201-210 of 301) with videos related to

Sort By:
Pageof 31
Practical Radiation Oncology|January 17, 2017
Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancerH D Heerkens, W A Hall, X A Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response AnalysisRanda Tao, Sunil Krishnan, Priya R Bhosale, et al.
Plos One|December 24, 2014
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implicationsChaitanya R Churi, Rachna Shroff, Ying Wang, et al.
Frontiers in Oncology|October 3, 2022
Radiation therapy for <i>de novo</i> anorectal cancer in patients with a history of prostate radiation therapyLara Hilal, Abraham J Wu, Marsha Reyngold, et al.
International Journal of Radiation Oncology, Biology, Physics|March 14, 2023
Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic CancerMarsha Reyngold, Sana D Karam, Carla Hajj, et al.
Annals of Surgical Oncology|January 20, 2012
Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapyChing-Wei D Tzeng, Jason B Fleming, Jeffrey E Lee, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 3, 2013
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancerChing-Wei D Tzeng, Aparna Balachandran, Mediha Ahmad, et al.
Advances in Radiation Oncology|June 17, 2025
Prospective Evaluation of a Novel Unidirectional Permanent Device for Intraoperative BrachytherapyAbraham J Wu, Irini Youssef, Gil'ad N Cohen, et al.
JAMA Oncology|March 11, 2021
Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic CancerMarsha Reyngold, Eileen M O'Reilly, Anna M Varghese, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancerChristopher H Crane, Lee M Ellis, James L Abbruzzese, et al.
Pageof 31